Authors: CLELAND ME HUDSON P POTTAGE AB YANG J KIM S SON M

Citation: Me. Cleland et al., THE VASOPROTECTIVE EFFECT OF CIRCULAN IN THE MICROCIRCULATION OF THE HAMSTER-CHEEK POUCH, Thrombosis and haemostasis, 1997, pp. 2775-2775

Authors: SIM AK MCCRAW AP CLELAND ME AIHARA A OTOMO S HOSODA K ARAKI H

Citation: Ak. Sim et al., A PRECLINICAL ASSESSMENT OF THE EFFECT OF LIPO-PGE(1) ON THROMBUS FORMATION AND THROMBUS DISAGGREGATION, Advanced drug delivery reviews, 20(2-3), 1996, pp. 165-170

Authors: SIM AK MCCRAW AP CLELAND ME LARDY C GUERRIER D

Citation: Ak. Sim et al., LCB 2853, A NEW THROMBOXANE ANTAGONIST - ANTITHROMBOTIC AND THROMBOLYTIC ACTIVITY IN THE HAMSTER-CHEEK POUCH, Thrombosis and haemostasis, 69(6), 1993, pp. 670-670

Authors: SIM AK MCCRAW AP CLELAND ME NAKANO Y KATO K

Citation: Ak. Sim et al., THE THROMBOLYTIC ACTIVITY OF MODIFIED UROKINASE - A METHOXY-POLYOXYETHYLENE-POLYOXYPROPYLENE-UROKINASE COPOLYMER (MUK), Thrombosis and haemostasis, 69(6), 1993, pp. 844-844

Authors: MCCRAW AP SIM AK CLELAND ME LARDY C GUERRIER D

Citation: Ap. Mccraw et al., THE VASOPROTECTIVE AND ANTIATHEROSCLEROTIC ACTION OF LCB-2853, A NOVEL THROMBOXANE-A(2) ANTAGONIST, Thrombosis and haemostasis, 69(6), 1993, pp. 1320-1320

Authors: MCCRAW AP SIM AK CLELAND ME SPIGNOLI G

Citation: Ap. Mccraw et al., ANTITHROMBOTIC ACTIVITY OF G619, A THROMBOXANE SYNTHASE INHIBITOR ANDTXA(2) RECEPTOR ANTAGONIST, Thrombosis and haemostasis, 69(6), 1993, pp. 1321-1321